Goblet cells populate wet-surfaced mucosa including the conjunctiva of the eye, intestine, and nose, among others. These cells function as part of the innate immune system by secreting high molecular weight mucins that interact with environmental constituents including pathogens, allergens, and particulate pollutants. Herein we determined whether IFN-γ, a Th1 cytokine increased in dry eye, alters goblet cell function. Goblet cells from rat and human conjunctiva were cultured. Changes in intracellular [Ca 2+ ] ([Ca 2+ ] i ), high molecular weight glycoconjugate secretion, and proliferation were measured after stimulation with IFN-γ with or without the cholinergic agonist carbachol. IFN-γ itself increased [Ca 2+ ] i in rat and human goblet cells and prevented the increase in [Ca 2+ ] i caused by carbachol. Carbachol prevented IFN-γ-mediated increase in [Ca 2+ ] i . This cross-talk between IFN-γ and muscarinic receptors may be partially due to use of the same Ca 2+ i reservoirs, but also from interaction of signaling pathways proximal to the increase in [Ca 2+ ] i . IFN-γ blocked carbachol-induced high molecular weight glycoconjugate secretion and reduced goblet cell proliferation. We conclude that increased levels of IFN-γ in dry eye disease could explain the lack of goblet cells and mucin deficiency typically found in this pathology. IFN-γ could also function similarly in respiratory and gastrointestinal tracts.
Introduction
The wet-surfaced mucosa including the conjunctiva of the eye, the intestine, colon, nose, bronchioles, Eustachian tube, and vagina contain goblet cells. These cells function as part of the innate immune system by secreting high molecular weight mucins that directly interact with environmental constituents including pathogens, allergens, and particulate pollutants.
Substantial experimental evidence demonstrates that goblet cells function in mucosal epithelial protection and disease pathogenesis in respiratory and gastrointestinal tracts. 1 , 2 In the ocular surface goblet cells are found in the epithelial layer of the conjunctiva, the mucous membrane that surrounds the cornea and lines the eyelids. These goblet cells are specialized cells that produce and secrete mucins, most notably the mucin (MUC) MUC5AC that lubricates and protects the ocular surface, maintaining its health. 3 , 4 Goblet cells are also integral participants in diseases of the ocular surface including allergic conjunctivitis, bacterial keratitis and conjunctivitis, and dry eye.
MUC5AC is a high molecular weight glycoconjugate that forms the mucous layer of the tear film. 5 The amount of MUC5AC found in the ocular surface is tightly controlled by goblet cell number, MUC5AC synthesis, and MUC5AC secretion. In inflammatory disorders such as dry eye, Sjögren's syndrome or ocular cicatricial pemphigoid goblet cells die or are nonfunctional. 6 -8 On the other hand, in diseases such as allergic conjunctivitis, higher goblet cell numbers are found. As early as in 1992, Lemp 9 suggested that either an increase or a decrease in the number of filled goblet cells was associated with ocular surface pathology.
Under normal conditions, goblet cell secretion is under neural control by the efferent parasympathetic nervous system. Cholinergic, muscarinic mediators that are analogs of the parasympathetic neurotransmitter acetylcholine are major stimuli. 10 Cholinergic agonists transmit their signal by activating the G protein G αq/ 11 that activates phospholipase C, which breaks down phosphatidylinositol 4,5 bisphosphate (PIP 2 ) producing inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol. The increase in IP 3 binds to its receptor in the endoplasmic reticulum to release Ca 2+ from intracellular stores thereby elevating the intracellular Ca 2+ concentration ([Ca 2+ ] i ). 11 The increase in [Ca 2+ ] i leads to activation of extracellular regulated kinase (ERK)1/2 (also known as p44, p42 mitogen activated protein kinase (MAPK)), and secretion of high molecular weight glycoconjugates including MUC5AC. 12 In airway epithelium, mucin secretion is dependent upon the calcium sensors Munc13-2 and sytnaptotagmin2. 13 These proteins have not yet been identified in the conjunctiva. Cholinergic agonists mediate goblet cell secretory responses to environmental changes under normal conditions. When inflammation develops in the ocular surface as occurs in dry eye, these responses may be altered. This alteration would lead to a change in goblet cell mucin production. In early disease mucus production can be increased as a protective response, but later in the disease goblet cell mucin production can be decreased leading to ocular surface pathology.
Interferon gamma (IFN-γ) is the major Th1-derived cytokine. This cytokine is implicated in several different immune responses, such as inflammation or graft rejection. IFN-γ is secreted by cytotoxic T cells, Th1 cells, and natural killer cells. 14 It binds to its receptor, IFN-γ-R, that is ubiquitously expressed at the cell surface on all cells except erythrocytes. 15 The main signaling pathway induced by IFN-γ is through the JAK-STAT intracellular signal transduction pathway leading to activation of STAT-1 target genes. 16 , 17 IFN-γ-R can also recruit and activate phosphatidylinositol-3 kinase (PI-3K), Src, or MyD88, that initiate signaling cascades involving ERK1/2, Akt or NF-κB.
In the conjunctival epithelium, IFN-γ induces squamous metaplasia, which leads to progressive goblet cell loss. Both changes are related to dry eye disease. Recently Zhang et al. 18 showed that IFN-γ caused goblet cell apoptosis in a mouse model of dry eye. However, the signaling pathways activated by this cytokine and its role regulating in goblet cell function remain unclear.
The purpose of this study was to determine if IFN-γ, a mediator of dry eye, directly regulates mucin production in rat and human conjunctival goblet cells. Thus, presence of IFN-γ-R-1, as well as effect on intracellular Ca 2+ signaling, mucin secretion, and goblet cell proliferation were measured after stimulation with IFN-γ alone or in the presence of a normal stimulus of secretion, a cholinergic agonist. We found that IFN-γ blocked the cholinergic agonist-stimulated increase in [Ca 2+ ] i , mucin secretion, and decreased goblet cell proliferation. Thus, IFN-γ leads to decreased goblet cell mucus production and contributes to the mucin deficiency found in dry eye disease.
Results

Goblet Cell Characterization
Identity of cells cultured from both rat and human conjunctiva was confirmed by immunofluorescence microscopy using the following markers: cytokeratins (CK) 4 (specific for stratified squamous non-goblet epithelial cells) and 7 (goblet cell specific keratin), 19 , 20 and lectins from Ulex europaeus agglutinin type 1 (UEA-1) (rat) or Helix pomatia agglutinin (HPA) (human). Lectins identify high molecular weight glycoconjugates including MUC5AC synthesized and secreted by goblet cells.
The majority of rat cells in culture were positive for both lectin UEA-1 (green) and CK7 (red) as shown in Figure 1a . To assure that lectins were identifying goblet cells, immunocytochemistry against UEA-1 and MUC5AC was performed in cultured cells ( Figure 1b) . We observed that UEA-1 and MUC5AC staining co-localized, showing that there were identifying the same mucous products. Human cultured cells were positive for lectin HPA (red) and CK7 (green), as shown in Figure 1c , and positive for MUC5AC ( Figure  1d ). Cultured cells did not express CK4 (data not shown). Additionally, the expression of MUC5AC in these cells and in conjunctival tissue from rat and human was confirmed by semi-quantitative real time RT-PCR ( Figure 1e ). MUC5AC was detected in both rat (left) and human (right) conjunctival tissue and in cultured goblet cells. MUC5AC mRNA levels were 277.7 times higher in cultured rat goblet cells that in rat conjunctiva, and 170.7 times higher in human goblet cells than in human conjunctiva. Therefore the overwhelming majority of cells in culture were goblet cells.
Goblet Cells Express IFN-γ-R1
To determine if conjunctival goblet cells were able to directly respond to IFN-γ, the presence of IFN-γ-R1, the receptor for this cytokine, was determined by immunofluorescence microscopy and by real time RT-PCR. IFN-γ-R1 protein expression was identified in both rat and human cultured cells (Figure 2a-b) . In addition, IFN-γ-R1 was detected in conjunctival tissue and cultured goblet cells (Figure 2c ). We confirmed that both rat and human cultured cells expressed the receptor needed for IFN-γ to be effective. 
IFN-γ Increases
IFN-γ Causes a Time-dependent Inhibition of a Cholinergic Agonist-Induced Increase in [Ca 2+ ] i in Goblet Cells
The effect of IFN-γ on carbachol-induced increase in [Ca 2+ ] i was evaluated at two different incubation times. The first time, 15 min, is a short treatment that indicates the immediate effect on intracellular Ca 2+ levels and the use of the different cellular Ca 2+ pools. The effect of a 15-min treatment was shown in Figure 3 and is used as a control in Figure 4 . The second time, 24 h, is used to study longer term activation of cytokine dependent signaling pathways probably involving synthesis of signaling mediators. In rat goblet cells, IFN-γ (3 ng/ml) increased peak A similar experiment was conducted using human goblet cells ( Figure 5 b and d) 
Effect of Inhibition of PI-3K and ERK1/2 on IFN-γ-and Cholinergic Agonist-Stimulated Increase in [Ca 2+ ] I in Goblet Cells
Phosphoinositide-3 kinase (PI-3K) and mitogen-activated protein kinase kinase (MEK) 1/2 form part of an alternative IFN-γ signaling cascade compared to STAT-1. 13 Rat goblet cells were preincubated with the PI-3K inhibitor LY294002 or the MEK1/2 inhibitor U0126 at 10 −5 M (prevents activation of ERK1/2) for 30 min and then stimulated with IFN-γ (3 ng/ml) or carbachol (10 −4 M).
IFN-γ increased [Ca 2+ ] i to 453.7 ± 82.9 nM (n=5) (Fig 6a and b) 
IFN-γ Induces Mucin Secretion and Blocks Cholinergic Agonist-Stimulated Mucin Secretion from Goblet Cells
Goblet cell secretion was evaluated after stimulation with 3 ng/ml IFN-γ or 10 −4 M carbachol. IFN-γ by itself did not have a significant effect on rat goblet cell secretion, and did not stimulate secretion from human cells (n=3) (Figure 7a and d) . As a positive control carbachol induced high molecular weight glycoconjugate secretion from both rat and human goblet cells to 1.60 ± 0.08 and 2.01 ± 0.20 fold increase over basal (n=3), respectively. This response is consistent with previous results. 26 The effect of IFN-γ on carbachol-induced secretion was determined at two times of incubation 15 min and 24 h. A 15 min treatment with IFN-γ did not have any significant effect on carbachol-induced secretion, in either rat or human goblet cells. In contrast, IFN-γ incubated for 24 h significantly blocked carbacholinduced secretion to 0.88 ± 0.06 and to 1.21 ± 0.23 in rat (p = 0.002, Figure 7b ) and human cells (p = 0.05, Figure 7c ), respectively. In rat cells a 120.0 % inhibition was obtained, whereas in human cells a 79.2 % inhibition was obtained.
These data suggest that activation of a long-term pathway such as JAK-STAT by IFN-γ can prevent cholinergic agonist stimulated secretion, but that stimulating a short-term pathway such as increasing the [Ca 2+ ] i cannot.
IFN-γ Decreases Goblet Cell Proliferation
Cell proliferation was measured in rat conjunctival goblet cells. A 24 h treatment with IFN-γ at 3 ng/ml decreased proliferation to 0.8 compared to basal value set as 1 (n=3) (p = 0.00018) (Fig 8) . As expected carbachol 10 −4 M did not have a significant effect on goblet cell proliferation after a 2 h treatment and IFN-γ added 24 h before carbachol did not alter proliferation either.
Discussion
The role of the Th1 cytokine IFN-γ has been widely studied in a number of diseases, such as dry eye, Steven-Johnson syndrome, or Sjögren's syndrome, where elevated levels of IFN-γ have been found. 27 -29 In humans, IFN-γ correlates with disease severity. 30 Our results demonstrate that IFN-γ, which is found to be increased in several inflammatory diseases of the conjunctiva, has a direct effect on conjunctival goblet cell function. We found that IFN-γ increases [Ca 2+ ] i , but did not stimulate goblet cell secretion. As a decrease in goblet cell mucin production plays a critical role in ocular surface inflammation 31 the most important finding of the present study is that IFN-γ blocks two of the three processes used by goblet cells to increase mucin production: mucin secretion and goblet cell proliferation. That is, IFN-γ prevented the increase in [Ca 2+ ] i and stimulation of secretion caused by cholinergic agonists. In addition, IFN-γ itself reduced goblet cell proliferation. These in vitro studies using isolated goblet cells were performed to determine the effect of IFN-γ on goblet cells not contaminated by other cell types. In vivo, is likely that cross talk between goblet and non-goblet cells occurs, involving multiple signaling cascades that could alter goblet cell signaling pathways. Therefore, further research in vivo is warranted.
Cultured goblet cells responded to IFN-γ in a concentration-dependent manner. IFN-γ from 0.1 ng/ml to 3 ng/ml showed progressive increase in [Ca 2+ ] i , whereas the highest concentration (10 ng/ml) did not. This suggests that at the highest concentration of IFN-γ, a Ca 2+ inhibitory signaling pathway is being activated. Interestingly, all four concentrations of IFN-γ blocked the effect of cholinergic agonists in a very similar way. This result suggests that IFN-γ at high concentrations is not using a Ca 2+ -dependent mechanism to block cholinergic agonist-mediated Ca 2+ responses. IFN-γ is known to activate other short-term signaling pathways 16 that will be investigated in future.
The mechanisms involved in short-and long-term responses induced by IFN-γ are likely to be different. Short-term blockade could be due to depletion of intracellular calcium reservoirs. Our results suggest that cholinergic agoinsts and IFN-γ are using, at least in part, the same intracellular Ca 2+ reservoirs. Major Ca 2+ reservoirs are the intracellular stores located in the endoplasmic reticulum 32 that are linked by Orai-1 and STIM1 to Ca 2+ influx. 33 , 34 This intracellular store is depleted by thapsigargin. The findings that: 1) intracellular Ca 2+ responses caused by cholinergic agonists and IFN-γ are both decreased after the addition of thapsigargin, and 2) the recovery of the intracellular Ca 2+ response after the re-addition of extracellular Ca 2+ support this hypothesis. In agreement with our hypothesis is the finding that cholinergic agonist treatment for 15 min also inhibited IFN-γ induced Ca 2+ responses and that a similar IFN-γ treatment inhibited the cholinergic Ca 2+ response.
Cholinergic agonists bind to muscarinic receptors and IFN-γ binds to its own receptor, IFN-γ-R. The main signaling pathway activated by IFN-γ-R is JAK-STAT, 17 a pathway probably not activated by muscarinic receptors. However, several of the alternative pathways activated by IFN-γ involve two kinases that form part of the muscarinic pathways, PI-3K and MEK1/2, 16 suggesting that an interaction based on these pathways may be occurring. For that reason we used specific inhibitors of these two kinases. We found that when PI-3K was blocked the response to cholinergic agonists was inhibited, but the response to IFN-γ was not altered. In contrast, when MEK1/2 was inhibited, goblet cell response to cholinergic agonists remained unaltered, while response to IFN-γ was significantly blocked. Even though cholinergic agonists and IFN-γ use the same cellular Ca 2+ stores, the mechanism by which they use these stores appears to be different. The short-term effect could also be independent of Ca 2+ , occur before the rise in intracellular Ca 2+ , or involve a direct effect on the muscarinic receptors. Because both IFN-γ and cholinergic agonists blocked one another's responses, a cross desensitization of both receptors may be occurring.
A hallmark of dry eye disease is reduced mucin secretion. Although the levels of [Ca 2+ ] i were not significantly blocked after 24 h incubation with IFN-γ alone, secretion induced by cholinergic agonists was reduced when there was a previous 24 h incubation with IFN-γ. This result is similar to the report of Contreras-Ruiz et al. of a reduction of cholinergic agonist-mediated mucin secretion of mouse goblet cells exposed to IFN-γ for 24 h. 35 As a 24 hr treatment of IFN-γ does not alter cholinergic agonist increase in [Ca 2+ ] i it is possible that activation of the JAK-STAT pathway that involves stimulation of transcription factors and synthesis of proteins could be responsible for the inhibition of secretion.
We showed in this study that IFN-γ decreases cultured goblet cell proliferation. This conclusion is supported by published results that associated increased IFN-γ levels with low numbers of goblet cells and increased apopotosis. 18 , 36 Interestingly, in some cells, IFN-γ stimulation led to JAK2-dependent transactivation of epidermal growth factor receptor (EGFR). 13 As activation of the EGFR is known to stimulate conjunctival goblet cell proliferation, it is unlikely that the JAK-STAT pathway plays a role in the IFN-γ blockade of cell proliferation. Blockade of goblet cell proliferation induced by IFN-γ could use another long-term mechanism or signaling pathway different from that used to decrease secretion.
A decrease in goblet cell proliferation could result from inhibition of the cell cycle or stimulation of apoptosis. When IFN-γ is present in the goblet cell environment, the proliferation of these cells is blocked (current study) and the apoptotic processes begin, as demonstrated by Zhang et al. 18 IFN-γ has been involved in goblet cell apoptosis through both extrinsic and intrinsic apoptosis pathways. 18 The main organelles that regulate Ca 2+
homeostasis are also the main sites of apoptotic regulation. 37 Thus, there could be an interaction between apoptotic and other Ca 2+ pathways that explain the long-term effect on IFN-γ on proliferation.
In previous studies, rat conjunctival goblet cells were found to behave in a similar manner as human goblet cells. 38 -40 Similarly, in the current study in both rat and human goblet cells, IFN-γ blocked carbachol-mediated increase in [Ca 2+ ] i and secretion in both species. Thus rat conjunctival goblet cells are an excellent model for human goblet cells, especially considering the difficulty in obtaining human conjunctiva.
The main limitation of using primary cultures is the high variability between experiments. We observed that especially in calcium experiments, where only a few cells are analyzed, increasing the risk of higher variation. In addition, in the case of human cells, that variability may be increased due to the use of cells from both male and females, as well as from elderly donors. However, even with those limitations, we found several significant effects.
We conclude that IFN-γ affects multiple processes that control the amount of mucin produced by goblet cells. IFN-γ itself decreases goblet cell number by blocking proliferation and potentially by stimulating apoptosis. In addition, we have shown that the normal goblet cell increase in [Ca 2+ ] i and mucin secretion, usually mediated by cholinergic agonists, is blocked by this Th1 cytokine. Taking all these data together, we conclude that the presence of IFN-γ could explain the mucin deficiency typically found in dry eye disease 6 since goblet cell number is diminished and the secretion of the remaining cells is blocked.
Methods
Materials
RPMI-1640 cell culture medium, penicillin/streptomycin, and L-glutamine were purchased from Lonza (Walkerville, IL). Fetal bovine serum (FBS) was from Atlanta Biologicals (Norcross, GA).
Antibodies against CK4, CK7, and MUC5AC were from Abcam (Cambridge, MA). The antibody against IFN γ receptor was from Novus Biologicals (Littleton, CO). Secondary antibodies were from Jackson Immunoresearch (West Grove, PA). Lectins UEA-1 and HPA were from Sigma-Aldrich (St. Louis, MO).
Primers for human IFN-γ receptor were from OriGene Technologies, Inc. (Rockville, MD), and those for rat were from SABioscience-Qiagen (Frederick, MD). The Superscript FirstStrand Synthesis system for reverse transcription polymerase chain reaction (RT-PCR) was from Invitrogen, (Carlsbad, CA). SYBR Green PCR Master Mix was from Applied Biosystems (Carlsbad, CA).
Recombinant Rat IFN-γ and recombinant Human IFN-γ (carrier-free) were purchased from BioLegend Inc. (San Diego, CA). Carbachol was purchased from Sigma (St. Louis, MO). Fura-2/AM was from Life Technologies (Grand Island, NY). The 35mm Glass Bottom Culture Dishes were from MatTek Corporation (Ashland, MA). Thapsigargin and 2-APB were from Sigma-Aldrich, and LY294002 and U0126 were from Tocris Bioscience (Minneapolis, MN).
Enzyme-linked lectin assay (ELLA) was from Pierce Biotechnology (Rockford, IL) and Amplex Red was from Invitrogen. The Cell Counting Kit-8 was purchased from Dojindo Molecular Technologies (Gaithersburg, MD).
Animals
Male Sprague-Dawley rats between 4 and 5 weeks of age were obtained from Taconic Farms (Germantown, NY). All experiments followed the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and were approved by the Schepens Eye Research Institute Animal Care and Use Committee. Rats were anesthetized with CO 2 for 2 min and then euthanized by decapitation. Forniceal and bulbar conjunctival tissues were removed from both eyes.
Human Tissue
Human conjunctival tissues were obtained from Heartland Lions Eye Bank (Columbia, MO) and Michigan Eye Bank (Ann Arbor, MI). This study adhered to the Tenets of the Declaration of Helsinki and was approved by the Schepens Eye Research Institute Human Studies Internal Review Board. Received tissues were normal bulbar and forniceal conjunctival tissues.
Cell Culture
Tissue samples were obtained from 29 rats and from 12 human donors. Rat and human conjunctival goblet cells were grown in organ culture as previously described. 38 , 41 Briefly, conjunctival tissue was carefully minced into small pieces, and placed in six-well plates. When cell outgrowth was observed, tissue explants were removed. Conjunctival cells were cultured from every sample, although goblet cells were not obtained from each piece. As early as 24 h after establishment of organ culture, cell outgrowth from the explant was observed. Cells were fed with RPMI-1640 medium supplemented with 10% FBS, 2 mM Lglutamine, and 100 μg/ml penicillin-streptomycin. Cells were maintained at 37° C in 5% CO 2 , and the medium was changed every other day. After 7-10 days, cells were trypsinized and passaged. Cells in passage 1 were used for all experiments.
Immunofluorescence microscopy
First-passage cultured cells were grown on glass cover slips and fixed in methanol or formaldehyde. To confirm that the cultured cells were goblet cells, these cells were stained with antibody against CK7, CK4, MUC5AC, and the lectins UEA-1 conjugated to FITC or HPA conjugated to TRITC. Cells were incubated for 2 h with a blocking solution. Thereafter, primary antibody anti-CK7, anti-CK4, or anti-MUC5AC at 1:100 dilution was added. After one hour, cover slips were washed with PBS, and then secondary antibody conjugated with Cy2 or Cy3 (at 1:200 dilution), and UEA-1 or HPA (at 1:500 dilution) were added for one hour. To detect cell nuclei, 6-diamidino-2-phenylindole (DAPI) was added to the mounting medium. The same protocol was used to determine the presence of IFN-y receptor, using an anti-IFN-y-R antibody. Negative controls included the omission of primary antibodies. Specificity of primary antibodies and lectins had been previously tested. Cells were viewed by fluorescence microscopy (Eclipse E80i, Nikon, Tokyo, Japan). Micrographs were taken with a digital camera (Spot, Diagnostic Instruments, Inc, Sterling Heights, MI).
RNA Isolation and Real Time Reverse Transcript PCR (RT 2 -PCR)
Briefly, RNA was extracted with TRIzol and total RNA was isolated according to manufacturer's instructions. One microgram of purified total RNA was used for complementary DNA (cDNA) synthesis using the Superscript First-Strand Synthesis system for RT-PCR.
RT 2 -PCR reaction was performed with 10 ng cDNA, 1 μl primers ( 
High Molecular Weight Glycoconjugate Secretion
For secretion assays, first-passage goblet cells were cultured in 24-well plates and grown to confluence. After serum starving for 24 h, cells were incubated with buffer alone (basal), carbachol (10 −4 M), or IFN-γ (3 ng/ml) for 24 h in serum-free RPMI 1640 supplemented with 0.5% bovine serum albumin. Goblet cell secretion was measured using ELLA. UEA-1 lectin conjugated to horseradish peroxidase was used to detect high molecular weight glycoconjugates, including the mucin MUC5AC produced by rat and human goblet cells. After incubation, the culture medium was collected and the amount of lectin-detectable glycoconjugates was measured. After collection of supernatant for the ELLA, cells in the 24-well plate were removed and sonicated. The cell homogenate was analyzed for total amount of protein using the Bradford protein assay. Bovine submaxillary mucin was used for the standard curve.
To perform the ELLA, standards and supernatants were placed into 96-well microplates and dried overnight at 60° C. The manufacturer's protocol was followed. UEA-1 was detected using Amplex Red. In the presence of hydrogen peroxide, Amplex Red is oxidized producing a fluorescent molecule. Fluorescence was then quantified using a fluorescence ELISA reader (Bio-Tek, Winooski, VT), using 530 nm and 590 nm excitation and emission wavelengths, respectively. The amount of high molecular weight glycoconjugate secretion was normalized to total protein in the homogenate, and expressed as fold increase over basal. Basal value was set at 1.
Proliferation
Proliferation was measured using Cell Counting Kit-8. Briefly, cells were serum starved for 24 h, treated with IFN-γ (3 ng/ml), for 24 h, and then stimulated with carbachol (10 −4 M) for 2 h. After stimulation, WST-8 product was added to the wells and after a 45 min incubation, absorbance was read in a spectrophotometer, following manufacturer's instructions.
Data Presentation and Statistical Analysis
Data were presented as mean ± standard error of the mean (SEM). Student's t-test was performed to analyze data and p ≤ 0.05 was considered statistically significant. 
